Compare HRMY & ALGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRMY | ALGT |
|---|---|---|
| Founded | 2017 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2020 | 2006 |
| Metric | HRMY | ALGT |
|---|---|---|
| Price | $32.44 | $71.82 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 10 |
| Target Price | $44.11 | ★ $97.30 |
| AVG Volume (30 Days) | ★ 799.5K | 465.1K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.97 | ★ 81.62 |
| EPS | ★ 2.71 | N/A |
| Revenue | $868,453,000.00 | ★ $2,606,579,000.00 |
| Revenue This Year | $19.75 | $9.42 |
| Revenue Next Year | $12.88 | $6.52 |
| P/E Ratio | $11.72 | ★ N/A |
| Revenue Growth | ★ 21.51 | 3.74 |
| 52 Week Low | $25.52 | $43.03 |
| 52 Week High | $40.87 | $118.00 |
| Indicator | HRMY | ALGT |
|---|---|---|
| Relative Strength Index (RSI) | 66.25 | 35.01 |
| Support Level | $32.13 | $57.67 |
| Resistance Level | $33.21 | $93.65 |
| Average True Range (ATR) | 1.32 | 4.54 |
| MACD | 0.19 | -1.16 |
| Stochastic Oscillator | 58.88 | 5.40 |
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of underserved cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in underserved cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates the maximum revenue, and Sunseeker Resort.